chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BLOOD CLOT IN BRAIN; LOWER LEFT BACK PAIN; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The Company is unable to perform follow-up to request batch/lot numbers.  On an unspecified date, she experienced blood clot in brain, and lower left back pain, and was hospitalized (date unspecified)  for about 12 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clot in brain and lower left back pain was not reported. This report was serious (Hospitalization Caused / Prolonged); Sender's Comments: V0 20210532694-COVID-19 VACCINE AD26.COV2.S-Blood clot in brain, Lower left back pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Tinnitus, ringing- buzzing sound in left ear.; booster; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date Nov2021 (Lot number: Fm8028) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: El3249, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: Jan2021, when the patient was 54 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Ek9231, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: Jan2021, when the patient was 54 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset Nov2021, outcome "unknown", described as "booster"; TINNITUS (non-serious) with onset 15Nov2021, outcome "not recovered", described as "Tinnitus, ringing- buzzing sound in left ear.". Therapeutic measures were not taken as a result of tinnitus.  Additional information: Vaccination time was 11:45 AM. Patient had no allergies. Reported Event: Tinnitus, ringing- buzzing sound in left ear. It's not going away. Noted symptom began approx 1 week after booster shot. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Device date was 02Dec2021.  No follow-up attempts are possible. No further information is expected.
day 6 of the flu and it is horrible; Initial information was received on 30-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves an unknown age and gender patient who experienced day 6 of the flu and it is horrible after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (unknown formulation) (lot number, expiry date, strength, frequency was unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient had a non-serious event day 6 of the flu and it is horrible (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Pt recv vax on 4/30/98; post vax pt exp vax site redness & swelling
Felt dizzy and not well- at work. Put head down between legs and next thing I remember is laying on the floor (having passed out for at least one minute). Tried to sit up and passed out again. When I woke up the second time (unknown duration) I was sweating over entire body and remained on the ground. Waited ten minutes until someone found me. EMT was called. Normal heart rate, blood pressure, EKG at scene. All blood work was within normal range. Hematocrit 12.1, blood glucose level 102 1.5 hours after episode. Spent approximately 5 hours under care of either EMT or emergency room care.
Constant mild headache on forehead and posterior head. Next day, had numbness/weakness on the entire left arm. This has almost resolved with residual numbness sensation on the left wrist dorsal aspect.
A non-serious spontaneous report of mild influenza has been received from a nurse concerning herself, an adult female, subsequent to FLUMIST. No medical history or concomitant medications were reported. The patient received her first dose of FLUMIST in mid-Sep-2009. For the past ten years ten years she had received a flu shot. Thirty six hours after receiving FLUMIST she experienced a mild case of the flu which caused her to miss a day of work. The event of influenza resolved.
flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) (seriousness criterion medically significant). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2022-437373 (Patient Link).; Sender's Comments: This case concerns a patient, with medical history (not reported), who experienced the serious unexpected event(s) of Influenza like illness. The event(s) started occurring approximately within 1 day(s) after the 1st dose of mRNA-1273, Moderna COVID-19 Vaccine. The rechallenge was considered NA. The benefit-risk relationship of mRNA-1273, Moderna COVID-19 Vaccine is not affected by this report.
I woke early AM with burning and pain in my left upper arm at the injection sight.  Had a significant headache and my neck was still on the right side.  Took Benadryl and 800 MG Ibuprofen.
This was a minor event that I was not going to report until I determined the duration. The time of onset above is just a rough estimate because it was not unexpected so I did not  take not of it. Later I realized that there was muscle soreness limiting the range of motion of my left arm when I reached behind my back which lasted for about 4 months.  It resolved without any treatment.
Initial case was received on 31 March 2010 from a consumer/parent. A 5 year old male patient received an injection (route and site unknown) of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative (lot number unknown) on 06 February 2010. The patient experienced an unspecified fever, nausea and weakness on 21 February 2010. He had no vaccines within the last year. He had no pre-existing medical conditions, no known allergies and no concomitant medications. As of this report he continued to be weak. Subsequently, on 06 March 2010 the patient received an injection (route and site unknown) of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative (lot number unknown). Post vaccination between 06 March 2010 and 17 March 2010 he experienced nausea, vomiting and a seizure, reported in case number 2010-01914. Documents held by sender: None.
Received 2nd COVID vaccine on 5/20/21. Ten hours after vaccine, he developed fever, chills, severe muscle pains, severe headache, & felt eyes were going to pop out of his head. He was bedridden. Symptoms lasted 36 hours, and he missed a day of work.
No further AE; temperature excursion involving multiple lot numbers for GARDASIL 9, MMR II, ROTATEQ, and RECOMBIV AX. Many of the vaccines have been administered to patients; This spontaneous report was received from a practice manager and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 24-AUG-2020, the patient was vaccinated with dose of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 injection, lot # 1660991, expiration date 27-APR-2021 for prophylaxis (strength, exact dose, route of administration were not reported).  Administered dose of vaccine experienced the temperature excursion of 1.1 degrees Celsius for 27 hours and 45 minutes and 9 degrees Celsius for 1 hour and 15 minutes on 04-AUG-2020. There were no previous temperature excursions reported. Digital Data Logger was involved. No adverse symptoms were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2010USA001083:Same Reporter
This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with the doses of improperly stored PEDVAXHIB (lot # M027882 with expiration date 14-APR-2019, lot # M014925 with expiration date 19-FEB-2019; dose and route of administration were not reported) for prophylaxis. No adverse effects were reported. The vaccines were stored in 34.71F for 24 hours and previously in 32.28 F for 8 hours and 46 minutes as well as 29.29 F for 96 hours. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted. Sender's Comments: US-009507513-1612USA008513: US-009507513-1612USA013573.
dose / was administered without reconstitution with the powder portion; dose / was administered without reconstitution with the powder portion; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 30th July 2021, the patient received Menveo. On 30th July 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provide are as follows: The case was reported by medical assistant. The age at vaccination was not reported. The reporter realized during inventory that one dose of Menveo was administered without reconstitution with the powder portion, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The administration of Menveo occurred to 3 different patients on Friday and was not identified which one of them had received the incomplete vaccine. No patient's identifiers, lot numbers or expiration dates were provided.  The health care professional informed would call us back in case patient was identified. The reporter consented to follow-up.
Initially swollen this morning, as morning progressed patient had developed erythema, warmth. Area is just below injection site.
Patient had no previous adverse History.  Fine the day of the shot. Next day in the morning she passed out.  I told her to notify PCP, ingest water and food, take off the day from work.  No ER visit was necessary unless she stayed the same or got worse.  Follow up today 11-15-21 at 5:30pm the patient had recovered with no more issues
Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 10 microgram. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box).    Concomitant medication was not provided.  Treatment information was not provided.  This case contains information for the 5th patient out of 18 child patients as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-723704 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723704:Patient 1(Master Case)
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Patient reported feeling lightheaded and dizzy. patient sat in chair, removed mask to get air and drank some water. 911 was called as a precaution. a cool compress was placed on back of pt neck as directed by 911. vitals were within normal limits. pt reported feeling normal and walked to ambulance to sign paperwork as he reported not needing to go to the hospital.
recently got Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (recently got Covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (recently got Covid). At the time of the report, COVID-19 (recently got Covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants medications reported.   Reporter did not allow further contact
After 4 years of Afib-free life, 24 hours following my 2nd booster 6/8/22, Rapid Afib appears. Went to the Hospital ER Thursday 6/9/22  & was treated with meds - eventually converted to normal sinus rhythm later in day. Given & prescribed Metoprolol 50mg/day. Eliquis also started. Same on Friday 6/9/22, but converted spontaneously before any further meds were given.  Doubled the Metoprolol from 50 to 100mg/day.
Ringing in the Ear post vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of TINNITUS (Ringing in the Ear post vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ringing in the Ear post vaccination). At the time of the report, TINNITUS (Ringing in the Ear post vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were not provided by reported. Treatment information were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-089095 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089095:
Pt had fever, chills, joint pain and swelling. Exam by physician. Pt advised to take ibuprofen.
Loss of taste; Dizziness; Reduced/impaired sense of smell.; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 11:15 (at the age of 53-year-old), as single dose for COVID-19 immunisation. Medical history of the patient included ruptured L4-L5 disc. The patient had a history of allergy to penicillin. Concomitant medications included hydrocodone 10mg (MANUFACTURER UNKNOWN), loratadine (CLARITIN OTC), Ibuprofen (ADVIL 400mg) and magnesium chloride (MAG); all for an unknown indication received within two weeks vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 11:15, the patient had reduced/impaired sense of smell and on the same day at 11:17, she had dizziness within 2 minutes of shot. After 03 hours, she had experienced extreme fatigue. On 26Mar2021 after 16 hours, she had complete loss of taste. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events dizziness, loss of taste, reduced/impaired sense of smell and extreme fatigue was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.
From faxed correspondence received on 11/1/02, it was reported that an 81 year old elderly female was vaccinated with Fluzone (lot # U0888AA) IM in the deltoid on 10/11/02. She complained of pain at injection site, severe bruising, and decreased range of motion the next day. She was seen on 10/28/02 without bruises, or abscess, but with loss of shoulder motion. Reportedly the patient recovered. This case is closed.
Fatigue, fever 101 and sore throat  6 hours after booster Pfizer vaccine.
Patient experienced local pain, erythema, swelling in the area of the Right deltoid, platysma, upper 2/3 of the trapezius, and upper 1/3 of the triceps. Onset was within 8 hours of vaccine administration. No systemic symptoms noted.  Exam otherwise unremarkable. Symptoms resolved completely within 24 hours.  He indicates similar response to previous dose of anthrax vaccine.
My initial two (Moderna) vaccines in March 2021 made me very ill (103/104 degree fever), but it lasted less than 24 hours.  I had my booster vaccine on December 27, 2021.  A few hours later I had a seizure.  I had at least three more over the next 12 hours.  Due to my disorientation and inability to speak or follow instructions, I was admitted to the hospital overnight.  I had significant memory loss from before my vaccination until about a week later.  I have had seizures in the past but it had been over 15 years since my last one, I was taking medication, and none of my known risk factors were present.  I also had never had multiple seizures or memory loss.  I had another seizure in August 2022 for no apparent reason and with no other health changes.
skin issue's , hot and cold sweats, stomach pains, migraines,  nausea, blurred vision, knee swelling, and aching , Pain in the back like a stabbing fan, Dots under skin, in all areas even head. Has thrown up blood once in the beginning and also slight anal bleeding. Swollen tongue, Hand cramps, finger cramps.  *diagnosed with ( henoch-schonlein)
two days after receiving vaccine arm became really swollen. On day 3 pt. had slight headache which continued. On 4/25/21, headache became worse and on 4/26/21 pt. checked BP and noticed it was rising.  On 4/26/21 pt. was sent home from work. Pt. was taken to Urgent Care that evening where BP was recorded as 205/89. Pt. was given unknown shot and instructed to take Ibuprofen.   on 4/27/21 pt. followed up with PCP, who prescribed Hydrochlorothiazide daily and Norco  prn for pain.  On afternoon of 4/27/21 after taking HCT and BP remained elevated at 190/93. Pt. instructed to go to ER. Per wife upon arrival to hospital BP was 129/90.  On the morning of 4/28/21 BP was down slightly to 189/90's
Difficultly swallowing, Off and on warm feelings - both of these symptoms lasting a month.  Swollen lymph nodes upper respiratory and neck.  Scratchy voice
1150 Student presented with nausea. Reports nausea started last night, vomited x 1 last night. Allowed to rest with relief. Returned to class 1230.
Patient woke up at approximately 1 AM complaining of joint pain.  She was sent back to bed by parent.  At approximately 7 AM she again awoke, this time complaining of an itchy back.  Upon further inspection a rash was found on her trunk area (both front and back), the left side of her face and on the upper half of the front of her thighs.  Rash was most severe on back of trunk.  Rash appeared as red, raised pinpoints.
This case was reported by a nurse and described the occurrence of injection site cellulitis in a 30 month old female pt who received Infanrix. On 8/18/04, the pt received the 4th dose of Infanrix in the left thigh (lot DTPA598A2). On 8/18/04, the pt also received injections of MMRII and Varivax. Approximately "48 hours" after the administration of Infanrix, on 8/20/04, the pt experienced an injection site reaction at the site of the Infanrix administration. The pt was seen by a physician, who noted a reaction "local to the injection site, but larger and more red and hot than normally seen". A dx of injection cellulitis was made. The pt was treated with "comfort and supportive measures". The event resolved on an unspecified date. The nurse considered the injection site cellulitis to probably be related to vaccination with Infanrix.
2 weeks after vaccine rash, raised, red, itchy to arms spread over entire body- except for the hands, feet, neck, head.